Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.
de Lamballerie X, Martin-Blondel G, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, Guyen SN, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Sanchez VP, Tardivon C, Blancho G, Lévy V. de Lamballerie X, et al. Among authors: cheminant m. J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.10.006. Epub 2022 Oct 8. J Infect. 2023. PMID: 36216187 Free PMC article. No abstract available.
Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak.
Kohn M, Alsuliman T, Lamure S, Cheminant M, Delage J, Merle De Boever C, Tudesq JJ, Marjanovic Z, Van de Wyngaert Z, Malard F, Brissot E, Rigaudeau S, Marque-Juillet S, Therby A, Cartron G, Rousselot P, Hermine O, Duléry R, Besson C. Kohn M, et al. Among authors: cheminant m. Leuk Lymphoma. 2022 Nov;63(11):2686-2690. doi: 10.1080/10428194.2022.2086249. Epub 2022 Jun 18. Leuk Lymphoma. 2022. PMID: 35719107 No abstract available.
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
Nguyen Y, Flahault A, Chavarot N, Melenotte C, Cheminant M, Deschamps P, Carlier N, Lafont E, Thomas M, Flamarion E, Lebeaux D, Charlier C, Rachline A, Guérin C, Ratiney R, Touchard J, Péré H, Rozenberg F, Lanternier F, Arlet JB, Avouac J, Boussaud V, Guillemain R, Vignon M, Thervet E, Scemla A, Weiss L, Mouthon L; AP-HP-Centre Monoclonal Antibodies Working Group. Nguyen Y, et al. Among authors: cheminant m. Clin Microbiol Infect. 2022 Dec;28(12):1654.e1-1654.e4. doi: 10.1016/j.cmi.2022.07.015. Epub 2022 Aug 1. Clin Microbiol Infect. 2022. PMID: 35926762 Free PMC article.
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V. Touret F, et al. Among authors: cheminant m. J Infect. 2023 May;86(5):e126-e129. doi: 10.1016/j.jinf.2023.02.002. Epub 2023 Feb 5. J Infect. 2023. PMID: 36750165 No abstract available.
A Transmissible Rash of Palms and Soles in a 58-Year-Old Man.
Guery R, Aguilar C, Schuffenecker I, Leruez-Ville M, Cheminant M, Lanternier F, Lecuit M, Lortholary O. Guery R, et al. Among authors: cheminant m. Clin Infect Dis. 2017 Jul 1;65(1):176-177. doi: 10.1093/cid/cix256. Clin Infect Dis. 2017. PMID: 29319786 No abstract available.
Novel Treatments of Adult T Cell Leukemia Lymphoma.
El Hajj H, Tsukasaki K, Cheminant M, Bazarbachi A, Watanabe T, Hermine O. El Hajj H, et al. Among authors: cheminant m. Front Microbiol. 2020 May 28;11:1062. doi: 10.3389/fmicb.2020.01062. eCollection 2020. Front Microbiol. 2020. PMID: 32547515 Free PMC article. Review.
Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype.
Marçais A, Lhermitte L, Artesi M, Laurent C, Durkin K, Hahaut V, Rosewick N, Suarez F, Sibon D, Cheminant M, Avettand-Fenoel V, Bruneau J, Georges M, Pique C, Van den Broeke A, Asnafi V, Hermine O. Marçais A, et al. Among authors: cheminant m. Leukemia. 2021 Mar;35(3):764-776. doi: 10.1038/s41375-020-0900-3. Epub 2020 Jun 17. Leukemia. 2021. PMID: 32555298 Free article.
Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
Cheminant M, Bruneau J, Kosmider O, Lefrere F, Delarue R, Gaulard P, Radford I, Derrieux C, Hermine O, Lemonnier F. Cheminant M, et al. Br J Haematol. 2015 Mar;168(6):913-6. doi: 10.1111/bjh.13170. Epub 2014 Oct 14. Br J Haematol. 2015. PMID: 25312805 Free article. No abstract available.
Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.
Cheminant M, Derrieux C, Touzart A, Schmit S, Grenier A, Trinquand A, Delfau-Larue MH, Lhermitte L, Thieblemont C, Ribrag V, Cheze S, Sanhes L, Jardin F, Lefrère F, Delarue R, Hoster E, Dreyling M, Asnafi V, Hermine O, Macintyre E. Cheminant M, et al. Haematologica. 2016 Mar;101(3):336-45. doi: 10.3324/haematol.2015.134957. Epub 2015 Dec 24. Haematologica. 2016. PMID: 26703963 Free PMC article. Clinical Trial.
76 results